Literature DB >> 8360040

Hospital initiated prescribing in the General Medical Services scheme.

T Fahey1, H Sinclair.   

Abstract

Twenty-seven general practitioners associated with the Department of Community Health and General Practice, TCD, agreed to record details of the drugs prescribed on 30 consecutive GMS prescriptions. Doctors were asked to indicate whether the items they were prescribing were initiated by themselves or by a hospital doctor and whether they agreed with the latter items in terms of their clinical appropriateness and cost. Information on 1,471 prescribed items was obtained from a total of 754 prescriptions. General practitioners initiated 63% of these items, hospital doctors 35% and in 2% the person responsible was unknown. Hospital initiated items accounted for 44.5% of total ingredient costs compared with 54% in general practice. General practitioners agreed with most of the hospital initiated items in terms of their clinical appropriateness and cost. Given the extent of hospital initiated GMS prescribing in this study there is a clear need to differentiate between those items originating in hospital and those in general practice for accountability purposes.

Entities:  

Mesh:

Year:  1993        PMID: 8360040

Source DB:  PubMed          Journal:  Ir Med J        ISSN: 0332-3102


  3 in total

1.  The influence of drug use in university hospitals on the pharmaceutical consumption in their surrounding communities.

Authors:  Adeline Gallini; Renaud Legal; Florence Taboulet
Journal:  Br J Clin Pharmacol       Date:  2013-04       Impact factor: 4.335

2.  [At what care level are cyclo-oxygenase-2 inhibitors prescribed?].

Authors:  M J Montero Fernández; F J Rodríguez Alcalá; N Valles Fernández; F López de Castro; M Esteban Tudela; B Cordero García
Journal:  Aten Primaria       Date:  2002-10-15       Impact factor: 1.137

3.  Prevalence of potentially inappropriate prescribing in older people in primary care and its association with hospital admission: longitudinal study.

Authors:  Teresa Pérez; Frank Moriarty; Emma Wallace; Ronald McDowell; Patrick Redmond; Tom Fahey
Journal:  BMJ       Date:  2018-11-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.